Author:
Labro M T,Amit N,Babin-Chevaye C,Hakim J
Abstract
The in vitro effects of RU 28965 (roxithromycin), a new semisynthetic macrolide, on human neutrophil activity were compared with those of erythromycin. RU 28965, at a concentration as low as 0.1 microgram/ml, significantly enhanced the phagocytosis and killing of Staphylococcus aureus by neutrophils. Erythromycin displayed a less stimulating effect in a dose-dependent manner. Phagocytosis of Klebsiella pneumoniae was also increased after incubation of neutrophils with RU 28965, but killing was not altered. Neutrophil chemotaxis, myeloperoxidase activity, and O2 consumption were unchanged in the presence of RU 28965.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference37 articles.
1. Studies on the effects of ingestion of a single 500 mg oral dose of erythromycin stearate on leucocyte motility and transformation and on release in vitro of prostaglandin E2 by stimulated leucocytes;Anderson R.;J. Antimicrob. Chemother.,1984
2. Further studies on erythromycin effects on cellular immune functions in vitro and in vivo. Enhancement of neutrophil motility by erythromycin combined with ascorbate or thiamine;Anderson R.;J. Antimicrob. Chemother.,1982
3. In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria;Barlam T.;Antimicrob. Agents Chemother.,1984
4. The role of oxygen and its derivatives in microbial pathogenesis and host defense. Annu;Beaman L. V.;Rev. Microbiol.,1984
5. In vitro activity of rosamycin, josamycin, erythromycin, and clindamycin against P-lactamase-negative and 3-lactamase-positive strains of Neisseria gonorrhoeae;Biddle J. W.;Antimicrob. Agents Chemother.,1979
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献